Constant expansion of applications linked with the high prevalence rate of neurological disorders supported by the large geriatric population along with huge product pipeline as well as growing FDA approvals in the neuromodulation market are expected to drive the growth of the Neuromodulation industry during the forecast period of 2020-2030.

The Neuromodulation Market is expected to grow at a CAGR of 12.8% from 2020-2030, according to a new research report by Next Move Strategy Consulting.

Neuromodulation is a process that involves the implantation of a small electrode directly into the brain or peripheral nerves along with pulse generators under skin. It is used for the treatment of various neurological disorders that directly affects the central & peripheral nervous system. Some of the major neurological disorders require neuromodulation include epilepsy, tremor, Alzheimer’s disease, Parkinson’s disease, chronic pain management and many more.

According to the report, constant growing demands for chronic pain management owing to the growth in surgical procedures, trauma cases and many more. There has been technological advancement along with the high prevalence rate of neurological disorders followed by the presence of large geriatric population. In addition, the expansion of wide applications associated with neuromodulation supported by the huge product pipeline along with new product launches in the market. On the other hand, growing FDA approval for new & advanced product is likely to affect the market trends over the forecast period.

However, high cost of Neurostimulators followed by the lack of skilled professionals is likely to hamper the market growth. Moreover, growing investments in the R&D activities supported by the growing awareness as well as development in healthcare expenditure is anticipated to provide numerous opportunities to the market in the coming few years.

Based on technology, the neuromodulation market share is segmented into internal neuromodulation and external neuromodulation. Internal neuromodulation dominates the global neuromodulation market in terms of market share and will be the dominant during the forecasted period. Based on biomaterial, the market is fragmented into metallic, polymeric, and ceramic. Polymeric biomaterials s expected to show significant CAGR and are expected to maintain its dominance during the forecast period. Based on application, the neuromodulation market is categorized into epilepsy, tremor, incontinence, depression, chronic pain management, failed back syndrome, dystonia, gastroparesis, Parkinson’s disease, urine incontinence, fecal incontinence, and other. Chronic pain management is the major application of neuromodulation and is expected to transform the neuromodulation market trend. Rapid growth in pain management is a major factors expected to maintain dominance over the forecast period.  

North America is likely to account for the highest market size & share of the neuromodulation market in the forecast period 2020–2030 owing to the presence of well developed healthcare infrastructure along with growing FDA approvals. In addition, technology advancement with the presence of major market players as well as a huge product pipeline may drive the market growth. Europe accounts for the second leading position in the neuromodulation market size. Asia Pacific is expected to be the fastest developing region in the neuromodulation market which is majorly driven by the large geriatric population along with the high prevalence rate of neurological disorders. Moreover, growing awareness among people with the development in healthcare expenditure is likely to enhance the market growth.

According to the report, some the key players in the neuromodulation market are St. Jude Medical, Inc., LivaNova PLC, Medtronic plc, Boston Scientific Corporation, BioControl Medical, Bioness Inc., EnteroMedics Inc, NeuroPace Inc, Aleva Neurotherapeutics SA, and  Nevro Corporation.

Browse key industry insights from the report in detail along with the table of contents: Neuromodulation Market by Technology Internal Neuromodulation, External Neuromodulation), Biomaterial Metallic, Polymeric, Ceramic), Application Epilepsy, Tremor, Incontinence, Depression, Chronic Pain Management, Failed Back Syndrome, Dystonia, Gastroparesis, Parkinsonʼs Disease, Urine Incontinence, Fecal Incontinence, Other)- Global Opportunity Analysis and Industry Forecast, 2020 2030

Key Insights from the Neuromodulation Market Report:

• Asia Pacific is the fastest growing Neuromodulation market owing to the rising geriatric population along with high prevalence rate followed by developed expenditure on healthcare &growing awareness among people.
• The polymeric biomaterial & Chronic pain management application dominates the segment and is expected to grow at significant CAGR to maintain the led in 2030.
• Some of the major players in the market are St. Jude Medical, Inc., LivaNova PLC, Medtronic plc, Boston Scientific Corporation, BioControl Medical, Bioness Inc., EnteroMedics Inc, NeuroPace Inc, Aleva Neurotherapeutics SA, and Nevro Corporation.

The report Neuromodulation market – segmented by technology, biomaterial, application and geography

Get a free sample of the Neuromodulation Market report

About Next Move Strategy Consulting

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to delivering high-quality, market research reports that help multinational companies to triumph over their competition and increase their industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining, and data analytics.

We have been servicing over 1000 customers globally including 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best-quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry-standard delivery solutions range from pre-consultation to after-sales services, provide an excellent client experience, and ensure the right strategic decision-making for businesses.

For more insights, browse reports